• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物性水肿的病因:二氢吡啶、噻唑烷二酮及其他致水肿药物的综述

Etiology of Drug-Induced Edema: A Review of Dihydropyridine, Thiazolidinedione, and Other Medications Causing Edema.

作者信息

Sinnathamby Evan S, Urban Bretton T, Clark Robert A, Roberts Logan T, De Witt Audrey J, Wenger Danielle M, Mouhaffel Aya, Willett Olga, Ahmadzadeh Shahab, Shekoohi Sahar, Kaye Alan D, Varrassi Giustino

机构信息

School of Medicine, Louisiana State University Health Sciences Center (LSUHSC) New Orleans, New Orleans, USA.

School of Medicine, Louisiana State University (LSU) Health, Shreveport, USA.

出版信息

Cureus. 2024 Feb 1;16(2):e53400. doi: 10.7759/cureus.53400. eCollection 2024 Feb.

DOI:10.7759/cureus.53400
PMID:38435190
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10908346/
Abstract

Edema is an accumulation of fluid in the body's tissues that affects millions of Americans yearly. It can affect multiple body parts, for example, the brain or eyes, but often occurs in the periphery, including the feet and legs. Medications, such as dihydropyridine and thiazolidinediones (TZDs), can be the etiology of edema. Edema can develop in association with problems in the vasculature or lymphatic flow. In recent years, a better understanding of these drug-induced mechanisms has been appreciated. Specifically, dihydropyridines can increase hydrostatic pressure and cause selective pre-capillary vessel vasodilation. TZDs can cause edema through increased vascular permeability and increased hydrostatic pressure. Specifically, peroxisome proliferator-activated receptor gamma (PPARγ) stimulation increases vascular endothelial permeability, vascular endothelial growth factor (VEGF) secretion, renal sodium, and fluid retention. Other drugs that can cause edema include neuropathic pain agents, dopamine agonists, antipsychotics, nitrates, nonsteroidal anti-inflammatory (NSAIDS), steroids, angiotensin-converting enzyme (ACE) inhibitors, and insulin. There are various clinical presentations of edema. Since multiple mechanisms can induce edema, it is important to understand the basic mechanisms and pathophysiology of drug-induced edema. Edema can even become fatal. For example, angioedema can occur from ACE inhibitor therapy. In this regard, it is considered a medical emergency when there is laryngeal involvement. This review aims to thoroughly appreciate the multiple causes of drug-induced edema and the ways it can be treated or prevented.

摘要

水肿是指体液在人体组织中的积聚,每年影响数百万美国人。它可累及身体多个部位,例如大脑或眼睛,但通常发生在身体外周,包括足部和腿部。药物,如二氢吡啶类和噻唑烷二酮类(TZDs),可能是水肿的病因。水肿可与血管系统或淋巴液流动问题相关联。近年来,人们对这些药物诱导机制有了更好的认识。具体而言,二氢吡啶类可增加流体静压并导致选择性毛细血管前血管舒张。噻唑烷二酮类可通过增加血管通透性和流体静压导致水肿。具体来说,过氧化物酶体增殖物激活受体γ(PPARγ)的刺激会增加血管内皮通透性、血管内皮生长因子(VEGF)分泌、肾脏钠潴留和液体潴留。其他可导致水肿的药物包括神经性疼痛药物、多巴胺激动剂、抗精神病药物、硝酸盐、非甾体抗炎药(NSAIDS)、类固醇、血管紧张素转换酶(ACE)抑制剂和胰岛素。水肿有多种临床表现。由于多种机制均可诱发水肿,因此了解药物性水肿的基本机制和病理生理学很重要。水肿甚至可能致命。例如,血管性水肿可由ACE抑制剂治疗引起。在这方面,当喉部受累时,它被视为医疗紧急情况。本综述旨在全面了解药物性水肿的多种病因以及治疗或预防方法。

相似文献

1
Etiology of Drug-Induced Edema: A Review of Dihydropyridine, Thiazolidinedione, and Other Medications Causing Edema.药物性水肿的病因:二氢吡啶、噻唑烷二酮及其他致水肿药物的综述
Cureus. 2024 Feb 1;16(2):e53400. doi: 10.7759/cureus.53400. eCollection 2024 Feb.
2
Renal and vascular mechanisms of thiazolidinedione-induced fluid retention.噻唑烷二酮类药物引起液体潴留的肾脏和血管机制。
PPAR Res. 2008;2008:943614. doi: 10.1155/2008/943614.
3
Adipose-specific effect of rosiglitazone on vascular permeability and protein kinase C activation: novel mechanism for PPARgamma agonist's effects on edema and weight gain.罗格列酮对血管通透性和蛋白激酶C激活的脂肪组织特异性作用:过氧化物酶体增殖物激活受体γ激动剂对水肿和体重增加作用的新机制。
FASEB J. 2006 Jun;20(8):1203-5. doi: 10.1096/fj.05-4617fje. Epub 2006 May 3.
4
Does Thiazolidinedione therapy exacerbate fluid retention in congestive heart failure?噻唑烷二酮类药物治疗会加重充血性心力衰竭中的液体潴留吗?
Pharmacol Ther. 2016 Dec;168:75-97. doi: 10.1016/j.pharmthera.2016.09.007. Epub 2016 Sep 4.
5
Activation of a retinoic acid receptor pathway by thiazolidinediones induces production of vascular endothelial growth factor/vascular permeability factor in OP9 adipocytes.噻唑烷二酮类药物通过激活视黄酸受体通路诱导 OP9 脂肪细胞产生血管内皮生长因子/血管通透性因子。
Eur J Pharmacol. 2013 May 5;707(1-3):95-103. doi: 10.1016/j.ejphar.2013.03.033. Epub 2013 Mar 28.
6
Thiazolidinediones and Edema: Recent Advances in the Pathogenesis of Thiazolidinediones-Induced Renal Sodium Retention.噻唑烷二酮类药物与水肿:噻唑烷二酮类药物诱导肾钠潴留发病机制的最新进展
PPAR Res. 2015;2015:646423. doi: 10.1155/2015/646423. Epub 2015 May 14.
7
Review of the Case Reports on Metformin, Sulfonylurea, and Thiazolidinedione Therapies in Type 2 Diabetes Mellitus Patients.二甲双胍、磺酰脲类和噻唑烷二酮类药物治疗 2 型糖尿病病例报告综述。
Med Sci (Basel). 2023 Aug 15;11(3):50. doi: 10.3390/medsci11030050.
8
Diabetic macular edema.糖尿病性黄斑水肿
Saudi J Ophthalmol. 2009 Jul;23(2):143-8. doi: 10.1016/j.sjopt.2009.06.002. Epub 2009 Aug 5.
9
Thiazolidinediones, peripheral edema, and type 2 diabetes: incidence, pathophysiology, and clinical implications.噻唑烷二酮类药物、外周性水肿与2型糖尿病:发生率、病理生理学及临床意义
Endocr Pract. 2003 Sep-Oct;9(5):406-16. doi: 10.4158/EP.9.5.406.
10
Thiazolidinediones and their fluid-related adverse effects: facts, fiction and putative management strategies.噻唑烷二酮类药物及其与液体相关的不良反应:事实、虚构内容及假定的管理策略。
Drug Saf. 2007;30(9):741-53. doi: 10.2165/00002018-200730090-00002.

引用本文的文献

1
Unexpected Adverse Effect of Haloperidol: Acute Tongue Angioedema in a Schizophrenic Patient-Case Report and Review.氟哌啶醇的意外不良反应:1例精神分裂症患者急性舌血管性水肿——病例报告及文献复习
Case Rep Psychiatry. 2025 Jun 24;2025:4133014. doi: 10.1155/crps/4133014. eCollection 2025.
2
Drug-induced macular oedema.药物性黄斑水肿
Eye (Lond). 2024 Oct;38(14):2828. doi: 10.1038/s41433-024-03117-x. Epub 2024 May 7.

本文引用的文献

1
Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion-dependent beta thalassaemia.钙通道阻滞剂预防输血依赖型β地中海贫血患者铁过载所致心肌病。
Cochrane Database Syst Rev. 2023 Nov 17;11(11):CD011626. doi: 10.1002/14651858.CD011626.pub3.
2
Insulin Edema Syndrome due to Rapid Glucose Correction in a Diabetic Patient.糖尿病患者快速血糖纠正所致胰岛素水肿综合征
Case Rep Med. 2022 Aug 16;2022:3027530. doi: 10.1155/2022/3027530. eCollection 2022.
3
Gabapentinoid-induced peripheral edema and acute heart failure: A translational study combining pharmacovigilance data and in vitro animal experiments.加巴喷丁类药物诱发的外周水肿和急性心力衰竭:一项结合药物警戒数据和体外动物实验的转化研究。
Biomed Pharmacother. 2022 May;149:112807. doi: 10.1016/j.biopha.2022.112807. Epub 2022 Mar 15.
4
Comparative peripheral edema for dihydropyridines calcium channel blockers treatment: A systematic review and network meta-analysis.二氢吡啶类钙通道阻滞剂治疗的外周性水肿比较:系统评价和网络荟萃分析。
J Clin Hypertens (Greenwich). 2022 May;24(5):536-554. doi: 10.1111/jch.14436. Epub 2022 Mar 2.
5
Peripheral edema: A common and persistent health problem for older Americans.周围性水肿:美国老年人常见且持续存在的健康问题。
PLoS One. 2021 Dec 16;16(12):e0260742. doi: 10.1371/journal.pone.0260742. eCollection 2021.
6
Lobeglitazone: A Novel Thiazolidinedione for the Management of Type 2 Diabetes Mellitus.罗格列酮:一种新型噻唑烷二酮类药物,用于治疗 2 型糖尿病。
Diabetes Metab J. 2021 May;45(3):326-336. doi: 10.4093/dmj.2020.0272. Epub 2021 Apr 19.
7
Drug-induced peripheral oedema: An aetiology-based review.药物引起的外周水肿:基于病因的综述。
Br J Clin Pharmacol. 2021 Aug;87(8):3043-3055. doi: 10.1111/bcp.14752. Epub 2021 Feb 20.
8
ACE inhibitor-mediated angioedema.血管紧张素转换酶抑制剂相关性血管水肿。
Int Immunopharmacol. 2020 Jan;78:106081. doi: 10.1016/j.intimp.2019.106081. Epub 2019 Dec 10.
9
Thiazolidinediones: the Forgotten Diabetes Medications.噻唑烷二酮类药物:被遗忘的糖尿病药物。
Curr Diab Rep. 2019 Nov 27;19(12):151. doi: 10.1007/s11892-019-1270-y.
10
Pathophysiological Mechanisms of Chronic Venous Disease and Implications for Venoactive Drug Therapy.慢性静脉疾病的病理生理机制及其对静脉活性药物治疗的影响。
Int J Mol Sci. 2018 Jun 5;19(6):1669. doi: 10.3390/ijms19061669.